Paper41270976
Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors.
Adefolaju A and 4 others. Adv Drug Deliv Rev, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors. Papers, record 41270976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41270976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Animals | |
| Precision Medicine | |
| Drug Development | |
| Drug Evaluation, Preclinical | |
| Clinical Trials as Topic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K12 TR004416 | NCATS NIH HHS | United States | K12TR004416 | PubMed | NIH RePORTER |
| U01 TR003715 | NCATS NIH HHS | United States | U01TR003715 | PubMed | NIH RePORTER |
References224
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38091874 | Applying artificial intelligence and computational modeling to nanomedicine. | Curr Opin Biotechnol | 2024 | https://conductscience.org/library/papers/38091874 | PubMed |
| 2 | 40585824 | Updates in the diagnosis and management of ductal adenocarcinoma of the pancreas. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/40585824 | PubMed |
| 3 | 39799339 | Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/39799339 | PubMed |
| 4 | 39367313 | Adaptive designs in clinical trials: a systematic review-part I. | BMC Med Res Methodol | 2024 | https://conductscience.org/library/papers/39367313 | PubMed |
| 5 | 37217193 | Explaining Blood-Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms. | J Med Chem | 2023 | https://conductscience.org/library/papers/37217193 | PubMed |
| 6 | 34610309 | Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models. | Cell Rep | 2021 | https://conductscience.org/library/papers/34610309 | PubMed |
| 7 | 37880806 | Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37880806 | PubMed |
| 8 | 37192626 | A living ex vivo platform for functional, personalized brain cancer diagnosis. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37192626 | PubMed |
| 9 | 39938519 | Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. | Cell Stem Cell | 2025 | https://conductscience.org/library/papers/39938519 | PubMed |
| 10 | 37733309 | Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37733309 | PubMed |
| 11 | 22137795 | Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. | Cancer Cell | 2011 | https://conductscience.org/library/papers/22137795 | PubMed |
| 12 | 38520909 | Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. | Lung Cancer | 2024 | https://conductscience.org/library/papers/38520909 | PubMed |
| 13 | 37957280 | A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine. | Commun Biol | 2023 | https://conductscience.org/library/papers/37957280 | PubMed |
| 14 | 39657679 | Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. | Cell Stem Cell | 2025 | https://conductscience.org/library/papers/39657679 | PubMed |
| 15 | 21874314 | Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. | Qual Life Res | 2012 | https://conductscience.org/library/papers/21874314 | PubMed |
| 16 | 39425931 | Protocol using ex vivo mouse brain slice culture mimicking in vivo conditions to study tumor growth and cell motility of glioblastoma cells. | STAR Protoc | 2024 | https://conductscience.org/library/papers/39425931 | PubMed |
| 17 | 33860824 | Challenges in CNS drug development and the role of imaging. | Psychopharmacology (Berl) | 2021 | https://conductscience.org/library/papers/33860824 | PubMed |
| 18 | 40313508 | Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment. | Front Toxicol | 2025 | https://conductscience.org/library/papers/40313508 | PubMed |
| 19 | 19897538 | FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. | Oncologist | 2009 | https://conductscience.org/library/papers/19897538 | PubMed |
| 20 | 37722087 | Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37722087 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41270976
GET https://conductscience.org/api/papers/v1/41270976/references?page=2